ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Pfizer has struck a deal with Strides Arcolab under which it will commercialize generic injectable and oral drugs in the U.S. supplied both by the Indian firm and its joint ventures with South Africa’s Aspen. David Simmons, president of Pfizer’s established products business, says the deal brings the number of products his business has licensed to more than 200. Among earlier agreements are deals with Claris Lifesciences and Aurobindo Pharma, two other Indian firms.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X